Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Exploring the effects of sleep loss on aging and cognitive decline

Official title: The Peripheral Blood Multi-Omics Study on the Association of Sleep Loss With Aging and Alzheimer's Disease

Run by First Affiliated Hospital of Zhejiang University · NCT06492109 · Data updated 2026-11-12

This study is testing how not getting enough sleep affects thinking and aging in healthy people and those with memory problems or Alzheimer's disease.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorFirst Affiliated Hospital of Zhejiang University
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedJune 20, 2024
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedJuly 31, 2025
Trial IDNCT06492109 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include healthy individuals, patients with mild cognitive impairment, and those diagnosed with Alzheimer's disease.

Probably not a fit

Patients with severe psychiatric conditions or significant medical issues that could interfere with study participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of sleep deprivation on cognitive function and aging by analyzing blood samples from participants of varying ages and cognitive levels. It includes healthy individuals, those with mild cognitive impairment (MCI), and Alzheimer's disease (AD) patients. Participants will undergo cognitive assessments and sleep screenings, with blood samples collected before and after sleep deprivation for multi-omics analysis. The goal is to identify molecular biomarkers that link sleep loss with aging and neurodegenerative diseases.

Why it matters

Potential benefit: If successful, this study could lead to new insights into the biological mechanisms of sleep loss and its effects on cognitive decline, potentially informing treatment strategies for neurodegenerative diseases.

How similar studies have gone: While there is ongoing research into sleep and cognitive function, this study's multi-omics approach to understanding the relationship between sleep loss and aging is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Signed informed consent form;
2. Meet the inclusion criteria for each arms.

Exclusion Criteria:

1. Failure to provide informed consent;
2. Inability to follow study procedures due to issues such as language barriers or cognitive impairment;
3. Regular use of medications that may alter the relationship between sleep and outcome variables (e.g., opioid medications, benzodiazepines, and Z drugs \[non-benzodiazepine hypnotics\]);
4. History of alcohol abuse, substance abuse, consciousness disorders, cerebrovascular disease, head injury, epilepsy, encephalitis, or other neurological disorders;
5. Diagnosis of schizophrenia, severe depression, anxiety disorders, or other severe psychiatric conditions;
6. Presence of severe arrhythmias, myocardial infarction within the last 6 months, severe pulmonary dysfunction, renal or hepatic insufficiency, severe anemia, severe gastrointestinal diseases, tumors, or other severe medical conditions.

Where it's running

  • The First Affiliated Hospital of Zhejiang University
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.